Search

Author/Creator Juillerat, Pascal

11. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease. Issue 11 (November 2016)

Authors:
Mottet, Christian; Schoepfer, Alain M.; Juillerat, Pascal; Cosnes, Jacques; Froehlich, Florian; Kessler-Brondolo, Vera; Seibold, Frank; Rogler, Gerhard; Vavricka, Stephan R.; Michetti, Pierre
Journal:
Inflammatory bowel diseases
Issue:
Volume 22:Issue 11(2016:Nov.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Factors Associated with Durable Response to Infliximab in Crohn's Disease 5 Years and Beyond: A Multicenter International Cohort. Issue 1 (January 2015)

Authors:
Juillerat, Pascal; Sokol, Harry; Froehlich, Florian; Yajnik, Vijay; Beaugerie, Laurent; Lucci, Matthew; Burnand, Bernard; Macpherson, Andrew J.; Cosnes, Jacques; Korzenik, Joshua R.
Journal:
Inflammatory bowel diseases
Issue:
Volume 21:Issue 1(2015:Jan.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Factors influencing the outcome of vedolizumab treatment: Real‐life data with objective outcome measurements. Issue 3 (26th February 2021)

Authors:
Mader, Orla; Juillerat, Pascal; Biedermann, Luc; Michetti, Pierre; Hruz, Petr; Pittet, Valerie; Rogler, Gerhard; Zahnd‐Straumann, Nadine; Seibold, Frank
Journal:
United European Gastroenterology journal
Issue:
Volume 9:Issue 3(2021)
Page Start:
398
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Fatigue in inflammatory bowel disease and its impact on daily activities. Issue 1 (7th November 2020)

Authors:
Schreiner, Philipp; Rossel, Jean‐Benoît; Biedermann, Luc; Valko, Philipp O.; Baumann, Christian R.; Greuter, Thomas; Scharl, Michael; Vavricka, Stephan R.; Pittet, Valérie; Juillerat, Pascal; Rogler, Gerhard; von Känel, Roland; Misselwitz, Benjamin
Other Names:
Abdelrahman Karim investigator.; Ademi Gentiana investigator.; Aepli Patrick investigator.; Thomas Amman investigator.; Anderegg Claudia investigator.; Antonino Anca‐Teodora investigator.; Archanioti Eva investigator.; Arrigoni Eviano investigator.; Aslan Nurullah investigator.; Bakker de Jong Di...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 53:Issue 1(2021)
Page Start:
138
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort. Issue 6 (June 2018)

Authors:
Godat, Sébastien; Fournier, Nicolas; Safroneeva, Ekaterina; Juillerat, Pascal; Nydegger, Andreas; Straumann, Alex; Vavricka, Stephan; Biedermann, Luc; Greuter, Thomas; Fraga, Montserrat; Abdelrahman, Karim; Hahnloser, Dieter; Sauter, Bernhard; Rogler, Gerhard; Michetti, Pierre; Schoepfer, Alain M.
Journal:
European journal of gastroenterology & hepatology
Issue:
Volume 30:Issue 6(2018:Jun.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease. (July 2019)

Authors:
Pittet, Laure F.; Verolet, Charlotte M.; Michetti, Pierre; Girardin, Marc; Juillerat, Pascal; Mottet, Christian; Maillard, Michel H.; Siegrist, Claire-Anne; Posfay-Barbe, Klara M.
Journal:
American journal of gastroenterology
Issue:
Volume 114:Number 7(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. Prospective Validation of CD-62L (L-Selectin) as Marker of Durable Response to Infliximab Treatment in Patients With Inflammatory Bowel Disease: A 5-Year Clinical Follow-up. Issue 2 (15th February 2021)

Authors:
Bravo, Francisco; Macpherson, Jamie A.; Slack, Emma; Patuto, Nicolas; Cahenzli, Julia; McCoy, Kathy D.; Macpherson, Andrew J.; Juillerat, Pascal
Journal:
Clinical and translational gastroenterology
Issue:
Volume 12:Issue 2(2021)
Page Start:
e00298
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. S712 Benefits of High versus Low Dose Upadacitinib as Maintenance Treatment in Ulcerative Colitis Patients Who Were Responders to 8-week Induction with Upadacitinib: Results From the U-ACHIEVE Phase 3 Maintenance Trial. (October 2022)

Authors:
Parkes, Gareth; Juillerat, Pascal; Gecse, Krisztina; Yao, Xuan; Zhou, Wen; Deng, Huiwen; Ilo, Dapo; Sanchez-Gonzalez, Yuri; Higgins, Peter D.
Other Names:
Feagan Brian G. presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e496
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. S771 Efficacy and Safety of Upadacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase 3 U-ACCOMPLISH Study. (October 2021)

Authors:
Vermeire, Severine; Danese, Silvio; Zhou, Wen; Pangan, Aileen; Greenbloom, Susan; D'Haens, Geert; Panés, Julian; Juillerat, Pascal; Lindsay, James; Loftus, Edward V.; Sandborn, William; Reinisch, Walter; Sanchez-Gonzalez, Yuri; Huang, Bidan; Xian, Wangang; Liu, Jianzhong; Weinreich, Michael; Pana...
Journal:
American journal of gastroenterology
Issue:
Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Page Start:
S357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗